The RNA interference of amino acid transporter LAT1 inhibits the growth of KB human oral cancer cells

Anticancer Research

Volumn 26, Issue 4 B, 2006, Pages 2943-2948

  Kim, Chang Hyun ^a   Park, Kyung Jin ^a   Park, Jung Rim ^a   Kanai, Yoshikatsu ^b   Endou, Hitoshi ^b   Park, Joo Cheol ^a   Kim, Do Kyung ^a  

^a Chosun University   (South Korea)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anticancer therapy; Cancer cells; Essential amino acids; L type amino acid transporter 1 (LAT1); Small interfering RNA (siRNA)

Indexed keywords

AMINO ACID TRANSPORTER; DOUBLE STRANDED RNA; L TYPE AMINO ACID TRANSPORTER 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL GROWTH; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; MOUTH CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

CARBON RADIOISOTOPES; CARCINOMA, SQUAMOUS CELL; CELL GROWTH PROCESSES; GENE SILENCING; HUMANS; KB CELLS; LARGE NEUTRAL AMINO ACID-TRANSPORTER 1; LEUCINE; MOUTH NEOPLASMS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 33746693725     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Christensen HN: Role of amino acid transport and countertransport in nutrition and metabolism. Physiol Rev 70: 43-77, 1990.
2. McGivan JD and Pastor-Anglada M: Regulatory and molecular aspects of mammalian amino acid transport. Biochem J 299: 321-334, 1994.
3. Oxender DL and Christensen HN: Evidence for two types of mediation of neutral amino acid transport in Ehrlich cells. Nature 197: 765-767, 1963.
4. Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E and Endou H: Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem 273: 23629-23632, 1998.
5. Yanagida O, Kanai Y, Chairoungdua A et al: Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim Biophys Acta 1514: 291-302, 2001.
6. Nakamura E, Sato M, Yang H et al: 4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer. J Biol Chem 274: 3009-3016, 1999.
7. Prasad PD, Wang H, Huang H et al: Human LAT1, a subunit of system L amino acid transporter: molecular cloning and transport function. Biochem Biophys Res Commun 255: 283-288, 1999.
8. +-independent neutral amino acid transporter with broad substrate selectivity. J Biol Chem 274: 19745-19751, 1999.
9. Sang J, Lim YP, Panzia MA, Finch P and Thompson NL: TA1, a highly conserved oncofetal complementary DNA from rat hepatoma, encodes an integral membrane protein associated with liver development, carcinogenesis, and cell activation. Cancer Res 55: 1152-1159, 1995.
10. Wolf DA, Wang S, Panzia MA, Bassily NH and Thompson NL: Expression of a highly conserved oncofetal gene, TA1/E16, in human colon carcinoma and other primary cancers: homology to Schistosoma mansoni amino acid permease and Caenorhabditis elegans gene products. Cancer Res 56: 5012-5022, 1996.
11. Kanai Y and Endou H: Heterodimeric amino acid transporters: molecular biology and pathological and pharmacological relevance. Curr Drug Metab 2: 339-354, 2001.
12. Kim DK, Kanai Y, Choi HW et al: Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells. Biochim Biophys Acta 1565: 112-121, 2002.
13. Burkhardt BR, Lyle R, Qian K et al: Efficient delivery of siRNA into cytokine-stimulated insulinoma cells silences Fas expression and inhibits Fas-mediated apoptosis. FEBS Lett 580: 553-560, 2006.
14. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K and Tuschl T: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498, 2001.
15. Notani PN: Epidemiology and prevention of head and neck cancer: a global view. In: Contemporary Issues in Oral Cancer. Saranath D (ed.). Oxford University Press, New Delhi, pp. 1-29, 2000.
16. Todd R, Donoff RB and Wong DT: The molecular biology of oral carcinogenesis: toward a tumor progression model. J Oral Maxillofac Surg 55: 613-623, 1997.
17. Lee SJ, Jang BC, Lee SW et al: Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-gamma-induced upregulation of B7-H1 (CD274). FEBS Lett 580: 755-762, 2006.
18. Yoon JH, Kim YB, Kanai Y, Endou H and Kim DK: Sequential increases in 4F2hc expression during DMBA-induced hamster buccal pouch carcinogenesis. Anticancer Res 23: 3877-3882, 2003.
19. Yoon JH, Kim YB, Kim MS et al: Expression and functional characterization of the system L amino acid transporter in KB human oral epidermoid carcinoma cells. Cancer Lett 205: 215-226, 2004.
20. Keum YS, Kim J, Lee KH et al: Induction of apoptosis and caspase-3 activation by chemopreventive [6]-paradol and structurally related compounds in KB cells. Cancer Lett 177: 41-47, 2002.
21. Shin KD, Lee MY, Shin DS et al: Blocking tumor cell migration and invasion with biphenyl isoxazole derivative KRIBB3, a synthetic molecule that inhibits Hsp27 phosphorylation. J Biol Chem 280: 41439-41448, 2005.
22. Kok SH, Hong CY, Kuo MYP et al: Comparison of norcantharidin cytotoxic effects on oral cancer cells and normal buccal keratinocytes. Oral Oncol 39: 19-26, 2003.
23. Miller MC 3rd, Johnson KR, Willingham MC and Fan W: Apoptic cell death induced by baccatinIII, a precursor of paclitaxel, may occur without G(2)/M arrest. Cancer Chemother Pharmacol 44: 444-452, 1999.